当前位置：
X-MOL 学术
›
Arthritis Rheumatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study
Arthritis & Rheumatology ( IF 11.4 ) Pub Date : 2022-07-13 , DOI: 10.1002/art.42282 Xenofon Baraliakos 1 , Atul Deodhar 2 , Maxime Dougados 3 , Lianne S Gensler 4 , Anna Molto 3 , Sofia Ramiro 5 , Alan J Kivitz 6 , Denis Poddubnyy 7 , Marga Oortgiesen 8 , Thomas Vaux 9 , Carmen Fleurinck 10 , Julie Shepherd-Smith 9 , Christine de la Loge 10 , Natasha de Peyrecave 10 , Désirée van der Heijde 11
Arthritis & Rheumatology ( IF 11.4 ) Pub Date : 2022-07-13 , DOI: 10.1002/art.42282 Xenofon Baraliakos 1 , Atul Deodhar 2 , Maxime Dougados 3 , Lianne S Gensler 4 , Anna Molto 3 , Sofia Ramiro 5 , Alan J Kivitz 6 , Denis Poddubnyy 7 , Marga Oortgiesen 8 , Thomas Vaux 9 , Carmen Fleurinck 10 , Julie Shepherd-Smith 9 , Christine de la Loge 10 , Natasha de Peyrecave 10 , Désirée van der Heijde 11
Affiliation
To assess the long-term safety, tolerability, and efficacy of bimekizumab in patients with active ankylosing spondylitis (AS).
中文翻译：
Bimekizumab 在活动性强直性脊柱炎患者中的安全性和有效性：IIb 期随机对照试验及其开放标签扩展研究的三年结果
评估 bimekizumab 在活动性强直性脊柱炎 (AS) 患者中的长期安全性、耐受性和疗效。
更新日期：2022-07-13
中文翻译：
Bimekizumab 在活动性强直性脊柱炎患者中的安全性和有效性：IIb 期随机对照试验及其开放标签扩展研究的三年结果
评估 bimekizumab 在活动性强直性脊柱炎 (AS) 患者中的长期安全性、耐受性和疗效。
京公网安备 11010802027423号